Evaluating blood loss after cesarean delivery using ultrasound
Ultrasound Use Compared With Standard Care for Diagnosis of Blood Loss After Cesarean Delivery: A Randomized Controlled Trial
This study is trying to see if using ultrasound can help new moms find out if they have anemia from blood loss after a cesarean delivery faster than regular lab tests.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 276 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | Female |
| Sponsor | Holy Family Hospital, Nazareth, Israel Academic / other |
| Locations | 1 site (Nazareth, North) |
| Trial ID | NCT06963047 on ClinicalTrials.gov |
What this trial studies
This study examines the effectiveness of ultrasound in diagnosing postpartum anemia due to blood loss after cesarean delivery compared to standard care. It focuses on the critical period following delivery, where timely diagnosis and treatment of anemia can significantly impact maternal health and mother-infant bonding. The study aims to determine if ultrasound can provide earlier detection of anemia than traditional laboratory tests, which may not reflect the lowest hemoglobin levels until 48-72 hours postpartum. By addressing postpartum hemorrhage and anemia, the study seeks to improve maternal outcomes and reduce associated risks.
Who should consider this trial
Good fit: Ideal candidates for this study are women over 18 who have delivered via cesarean section and can provide informed consent.
Not a fit: Patients who may not benefit include those with preoperative coagulation disorders or those requiring intensive care post-surgery.
Why it matters
Potential benefit: If successful, this approach could lead to earlier diagnosis and treatment of postpartum anemia, improving maternal health and reducing complications.
How similar studies have performed: While the approach of using ultrasound for this purpose is innovative, similar studies have not been widely reported, indicating this may be a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women who delivered by a cesarean section. * Age over 18. * Fluent in Hebrew or Arabic. * Signed informed consent form. Exclusion Criteria: * Lack of consent or inability to provide informed consent. * Inability to perform a post-surgical ultrasound, such as post-surgery hospitalization in the intensive care unit. * Women with preoperative coagulation disorders. * Women whose clinical condition requires a post-cesarean ultrasound examination.
Where this trial is running
Nazareth, North
- Holy family hospital — Nazareth, North, Israel (Recruiting)
Study contacts
- Study coordinator: Raed Sa, MD
- Email: r.salim@hfhosp.org
- Phone: +972544986960
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.